Domov › Nemalobunkový karcinóm pľúc › Illinois › Cicero
Klinické štúdie Nemalobunkový karcinóm pľúc v meste Cicero, IL
24 štúdií pre Nemalobunkový karcinóm pľúc hľadá účastníkov v zariadeniach v meste Cicero a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Prebieha náborFáza 1/2
- Hope And Healing Cancer Services /ID# 276223, Hinsdale · 10 míľ odtiaľ
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Prebieha náborFáza 3
- Edward Hines Jr VA Hospital, Hines · 4 míľ odtiaľ
- Advocate Christ Medical Center, Oak Lawn · 9 míľ odtiaľ
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Prebieha náborFáza 3
- Northwestern Medicine Oak Brook, Oak Brook · 9 míľ odtiaľ
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Prebieha náborFáza 3
- Hope and Healing Cancer Services, Hinsdale · 10 míľ odtiaľ
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Prebieha náborFáza 3
- Advocate Christ Medical Center, Oak Lawn · 9 míľ odtiaľ
- Hope and Healing Cancer Services, Hinsdale · 10 míľ odtiaľ
- Endeavor Health, Elmhurst · 10 míľ odtiaľ
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Prebieha náborFáza 2
- Hope and Healing Clinical Research, Hinsdale · 10 míľ odtiaľ
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Prebieha náborFáza 3
- Research Site, Hinsdale · 10 míľ odtiaľ
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Prebieha náborFáza 3
- Affiliated Oncologists, LLC, Chicago Ridge · 10 míľ odtiaľ
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Prebieha náborFáza 3
- Research Site, Hinsdale · 10 míľ odtiaľ
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Prebieha náborFáza 2/3
- Loyola University Medical Center, Maywood · 5 míľ odtiaľ
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
Prebieha náborFáza 3
- Hope and Healing Cancer Services, Hinsdale · 10 míľ odtiaľ
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Prebieha náborFáza 3
- Affiliated Oncologists, LLC, Chicago Ridge · 10 míľ odtiaľ
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Prebieha náborFáza 3
- Research Site, Hinsdale · 10 míľ odtiaľ
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Prebieha náborFáza 3
- Research Site, Hinsdale · 10 míľ odtiaľ
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Prebieha náborFáza 3
- Northwestern Medicine Oak Brook, Oak Brook · 9 míľ odtiaľ
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Prebieha náborFáza 3
- Elmhurst Hospital Nancy Knowles Cancer Center, Elmhurst · 10 míľ odtiaľ
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Prebieha náborFáza 2
- Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · 3 míľ odtiaľ
- Edward Hines Jr VA Hospital, Hines · 4 míľ odtiaľ
- Loyola University Medical Center, Maywood · 5 míľ odtiaľ
- a 2 ďalších
MYLUNG Consortium Part 3: Observational Study
Prebieha náborObservačná štúdia
- Affiliated Oncologists, LLC, Chicago Ridge · 10 míľ odtiaľ
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Prebieha náborFáza 2
- Edward Hines Jr VA Hospital, Hines · 4 míľ odtiaľ
- Loyola University Medical Center, Maywood · 5 míľ odtiaľ
- Northwestern Medicine Oak Brook, Oak Brook · 9 míľ odtiaľ
- a 3 ďalších
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Prebieha náborFáza 2/3
- Loyola University Medical Center, Maywood · 5 míľ odtiaľ
- Northwestern Medicine Oak Brook, Oak Brook · 9 míľ odtiaľ
- Advocate Christ Medical Center, Oak Lawn · 9 míľ odtiaľ
- a 2 ďalších
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Prebieha náborFáza 2
- Edward Hines Jr VA Hospital, Hines · 4 míľ odtiaľ
- Loyola University Medical Center, Maywood · 5 míľ odtiaľ
- Northwestern Medicine Oak Brook, Oak Brook · 9 míľ odtiaľ
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Prebieha náborObservačná štúdia
- Advocate Christ Medical Center, Oak Lawn · 9 míľ odtiaľ
- Advocate Outpatient Center - Oak Lawn, Oak Lawn · 9 míľ odtiaľ
- Advocate High Tech Medical Park, Palos Heights · 12 míľ odtiaľ
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Prebieha nábor
- Edward Hines Jr. VA Hospital, Hines, IL, Hines · 4 míľ odtiaľ
GEMINI-NSCLC: NSCLC Biomarker Study
Prebieha náborObservačná štúdia
- Hope and Healing Cancer Services, Hinsdale · 10 míľ odtiaľ
Štúdie Nemalobunkový karcinóm pľúc v iných mestách
- Houston, TX145 štúdií
- New York City, NY121 štúdií
- Arlington, VA104 štúdií
- Nashville, TN97 štúdií
- Boston, MA90 štúdií
- Los Angeles, CA87 štúdií
- St. Louis, MO73 štúdií
- Chicago, IL61 štúdií
- Baltimore, MD60 štúdií
- San Antonio, TX59 štúdií
- Columbus, OH57 štúdií
- Washington, DC55 štúdií
Iné štúdie v Cicero
- Rakovina pľúc17 štúdií
- Rakovina prostaty14 štúdií
- Rakovina (všetky typy)13 štúdií
- Rakovina prsníka11 štúdií
- Akútna myeloidná leukémia11 štúdií
- Kolorektálny karcinóm10 štúdií
- Rakovina močového mechúra8 štúdií
- Melanóm7 štúdií
- Kardiovaskulárne ochorenia7 štúdií
- Metastatická rakovina7 štúdií
- Mnohonásobný myelóm6 štúdií
- Burkitov lymfóm6 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.